July 07, 2016

Authors:
Kaspar Van den Dries, Senior Director Formulation Sciences
Michiel Heslinga, Program Manager, Global Integration

In this webcast recording, we review the challenges which are experienced in early stage development of solid oral dosage forms.

We look at the implications of these challenges on a development program and discuss hurdles such as:

  • Bioavailability challenges of poorly soluble molecules early on in development
  • Development of paediatric dosage forms
  • The complexity of the CMC work stream from early development to commercial supply